PTC THERAPEUTICS, INC. — Director's Dealing 2017

Jan 6, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2017-01-03

Reporting Person: Almstead Neil Gregory (EVP Research Pharma Ops & Tech)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-03	Common Stock	A	6000	—	Acquired	16000	Direct
2017-01-03	Common Stock	A	720	—	Acquired	2765	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-01-03	Stock Option (Right To Buy)	$11.23	A	35000	Acquired	2027-01-02	Common Stock (35000.0)	Direct

Footnotes

F1: Restricted stock award vests in four equal annual installments over four years, commencing on January 3, 2018.

F2: Restricted stock unit (RSU) award vests in four equal annual installments over four years, commencing on January 3, 2018. Upon vesting, each RSU will convert into one share of the issuer.

F3: Includes 750 RSUs (previously reported in Table II), granted on January 4, 2016, which vest in equal installments over four years on each anniversary of the grant date.

F4: This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.